Phase III Study, V-15-32, of Gefitinib Versus Docetaxel in Previously Treated Japanese Patients With Non–Small-Cell Lung Cancer

Authors

Keywords

Journal

Volume 26, Issue 26, Pages 4244-4252

Publisher

American Society of Clinical Oncology (ASCO)

Online

2008-09-09

DOI

10.1200/jco.2007.15.0185

Discuss science. Find collaborators. Network.

Join a conversation

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now